Sponsored By

2015 MDEA Finalists: DuoResp Spiromax

DuoResp Spiromax  DuoResp Spiromax, manufactured by Teva Pharmaceuticals Europe (UK) is a dry-powder inhaler for existing medicines for asthma and COPD that uses an intuitive design to minimize the training required for patients and provide consistent drug delivery across inspiratory flow rates.

April 30, 2015

1 Min Read
2015 MDEA Finalists: DuoResp Spiromax

DuoResp Spiromax

 

DuoResp Spiromax, manufactured by Teva Pharmaceuticals Europe (UK) is a dry-powder inhaler for existing medicines for asthma and COPD that uses an intuitive design to minimize the training required for patients and provide consistent drug delivery across inspiratory flow rates.

Supply/design credit: Gerresheimer  

arrow-for-slideshow-left.jpg          arrow-for-slideshow-right.jpg

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like